Compumedics Limited
ASX:CMP.AX
0.305 (AUD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 49.719 | 42.408 | 37.756 | 35.74 | 35.069 | 41.505 | 37.002 | 34.417 | 37.544 | 33.495 | 30.841 | 27.15 | 27.915 | 31.265 | 32.611 | 38.181 | 38.582 | 36.871 | 38.877 | 38.499 | 34.339 | 32.438 | 19.747 | 16.639 | 0 | 0 | 0 |
| Cost of Revenue
| 23.907 | 20.818 | 18.436 | 16.578 | 17.057 | 16.736 | 15.815 | 15.366 | 17.615 | 15.453 | 14.554 | 13.33 | 14.096 | 13.168 | 13.274 | 16.205 | 16.574 | 15.384 | 18.024 | 17.864 | 14.58 | 14.17 | 7.925 | 0 | 0 | 0 | 0 |
| Gross Profit
| 25.812 | 21.59 | 19.32 | 19.162 | 18.012 | 24.769 | 21.187 | 19.051 | 19.929 | 18.042 | 16.287 | 13.82 | 13.819 | 18.097 | 19.337 | 21.976 | 22.008 | 21.487 | 20.853 | 20.635 | 19.759 | 18.268 | 11.822 | 16.639 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.519 | 0.509 | 0.512 | 0.536 | 0.514 | 0.597 | 0.573 | 0.554 | 0.531 | 0.539 | 0.528 | 0.509 | 0.495 | 0.579 | 0.593 | 0.576 | 0.57 | 0.583 | 0.536 | 0.536 | 0.575 | 0.563 | 0.599 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.743 | 5.461 | 4.056 | 4.388 | 3.843 | 5.538 | 5.327 | 6.934 | 7.242 | 5.836 | 6.291 | 5.978 | 4.635 | 4.702 | 4.876 | 4.866 | 4.588 | 4.6 | 7.312 | 7.883 | 6.5 | 6.708 | 0.832 | 0.871 | 0 | 0 | 0 |
| General & Administrative Expenses
| 7.082 | 6.412 | 5.644 | 6.116 | 5.927 | 6.012 | 5.481 | 5.641 | 5.262 | 4.565 | 4.603 | 4.476 | 4.426 | 4.485 | 4.253 | 4.99 | 4.852 | 4.277 | 4.798 | 5.019 | 3.486 | 4.23 | 3.658 | 2.684 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 14.056 | 13.251 | 9.483 | 8.26 | 8.998 | 8.471 | 7.517 | 6.893 | 6.438 | 6.801 | 5.844 | 5.905 | 6.631 | 7.432 | 8.015 | 9.756 | 10.85 | 10.573 | 9.972 | 10.323 | 6.842 | 6.915 | 5.914 | 2.862 | 0 | 0 | 0 |
| SG&A
| 21.11 | 19.663 | 15.127 | 14.376 | 14.925 | 14.483 | 12.998 | 12.534 | 11.7 | 11.366 | 10.447 | 10.381 | 11.057 | 11.917 | 12.268 | 14.746 | 15.702 | 14.85 | 14.77 | 15.342 | 10.328 | 11.145 | 9.572 | 5.547 | 0 | 0 | 0 |
| Other Expenses
| 0 | 0.555 | 1.962 | 0.708 | 1.265 | 0.793 | 0.637 | 0.782 | 0.76 | 0.999 | 0.882 | 0.94 | 0.601 | -1.831 | -1.209 | 0.925 | -0.321 | -1.043 | 0.277 | -0.758 | -0.254 | 0.148 | 0.101 | -13.247 | -0.118 | 1.974 | 0.12 |
| Operating Expenses
| 26.853 | 25.124 | 19.183 | 18.764 | 18.768 | 19.421 | 17.493 | 17.633 | 16.718 | 15.356 | 14.704 | 14.688 | 16.867 | 17.671 | 17.144 | 20.054 | 20.29 | 19.915 | 22.082 | 24.221 | 17.299 | 37.677 | 14.322 | 1.183 | -0.118 | 1.974 | 0.12 |
| Operating Income
| -1.041 | -3.534 | 0.137 | 0.398 | -0.756 | 5.348 | 3.694 | 1.418 | 3.211 | 2.686 | 1.583 | -0.868 | -2.974 | -1.311 | 0.384 | 2.882 | 0.46 | 1.498 | -2.293 | -3.928 | 2.094 | -20.343 | -1.919 | -1.183 | -0.118 | 1.974 | -0.12 |
| Operating Income Ratio
| -0.021 | -0.083 | 0.004 | 0.011 | -0.022 | 0.129 | 0.1 | 0.041 | 0.086 | 0.08 | 0.051 | -0.032 | -0.107 | -0.042 | 0.012 | 0.075 | 0.012 | 0.041 | -0.059 | -0.102 | 0.061 | -0.627 | -0.097 | -0.071 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.28 | -3.185 | 1.561 | 0.378 | -6.747 | -0.261 | -0.207 | -0.312 | -0.405 | -0.675 | -0.611 | -0.414 | 0.601 | -1.831 | -1.209 | 0.925 | -0.321 | -1.043 | 0.277 | -0.758 | -0.254 | 0.148 | 0.101 | -13.247 | -0.158 | -0.111 | 1.362 |
| Income Before Tax
| 0.239 | -6.719 | 1.698 | 0.776 | -7.503 | 5.087 | 3.487 | 1.106 | 2.806 | 2.011 | 0.972 | -1.282 | -1.787 | -0.767 | 0.451 | 2.729 | 0.683 | 0.123 | -1.595 | -3.897 | 2.409 | -18.965 | -2.496 | 2.801 | -0.276 | 1.863 | 1.242 |
| Income Before Tax Ratio
| 0.005 | -0.158 | 0.045 | 0.022 | -0.214 | 0.123 | 0.094 | 0.032 | 0.075 | 0.06 | 0.032 | -0.047 | -0.064 | -0.025 | 0.014 | 0.071 | 0.018 | 0.003 | -0.041 | -0.101 | 0.07 | -0.585 | -0.126 | 0.168 | 0 | 0 | 0 |
| Income Tax Expense
| 0.738 | -0.597 | 0.341 | -0.222 | -1.665 | 1.071 | 0.703 | 0.199 | 0.467 | 0.041 | 0.063 | 0.207 | 1.042 | -0.848 | -1.028 | 1.485 | -0.073 | -0.172 | -0.025 | -3.897 | 2.409 | -18.965 | -2.496 | 2.801 | -0.276 | 1.863 | 1.242 |
| Net Income
| -0.499 | -6.122 | 1.357 | 0.998 | -5.838 | 4.016 | 2.784 | 1.305 | 3.273 | 1.97 | 0.909 | -1.489 | -2.829 | 0.081 | 0.414 | 2.727 | 0.756 | 0.123 | -1.595 | -3.898 | 2.397 | -18.557 | -1.898 | 1.971 | -0.095 | 1.215 | 0.788 |
| Net Income Ratio
| -0.01 | -0.144 | 0.036 | 0.028 | -0.166 | 0.097 | 0.075 | 0.038 | 0.087 | 0.059 | 0.029 | -0.055 | -0.101 | 0.003 | 0.013 | 0.071 | 0.02 | 0.003 | -0.041 | -0.101 | 0.07 | -0.572 | -0.096 | 0.118 | 0 | 0 | 0 |
| EPS
| -0.003 | -0.035 | 0.008 | 0.006 | -0.033 | 0.023 | 0.016 | 0.007 | 0.019 | 0.012 | 0.005 | -0.009 | -0.018 | 0.001 | 0.003 | 0.017 | 0.005 | 0.001 | -0.011 | -0.028 | 0.017 | -0.13 | -0.014 | 0.017 | -0.001 | 0.009 | 0.006 |
| EPS Diluted
| -0.003 | -0.035 | 0.008 | 0.006 | -0.033 | 0.023 | 0.016 | 0.007 | 0.019 | 0.012 | 0.005 | -0.009 | -0.018 | 0.001 | 0.003 | 0.017 | 0.005 | 0.001 | -0.011 | -0.028 | 0.017 | -0.13 | -0.014 | 0.017 | -0.001 | 0.009 | 0.006 |
| EBITDA
| 0.451 | -2.521 | 1.349 | 1.855 | 0.908 | 5.679 | 3.956 | 1.733 | 3.482 | 2.999 | 1.869 | -0.548 | -0.097 | 0.699 | 0.984 | 3.731 | 1.397 | 1.459 | -0.952 | -2.352 | 3.148 | -0.92 | -0.636 | 3.04 | -0.118 | 1.974 | 1.383 |
| EBITDA Ratio
| 0.009 | -0.059 | 0.036 | 0.052 | 0.026 | 0.137 | 0.107 | 0.05 | 0.093 | 0.09 | 0.061 | -0.02 | -0.003 | 0.022 | 0.03 | 0.098 | 0.036 | 0.04 | -0.024 | -0.061 | 0.092 | -0.028 | -0.032 | 0.183 | 0 | 0 | 0 |